Lyra Therapeutics Inc (LYRA)
0.3859
+0.02
(+4.98%)
USD |
NASDAQ |
May 17, 16:00
0.3879
0.00 (0.00%)
Pre-Market: 20:00
Lyra Therapeutics Price to Book Value: 0.3013 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.3013 |
| May 16, 2024 | 0.2892 |
| May 15, 2024 | 0.2799 |
| May 14, 2024 | 0.2926 |
| May 13, 2024 | 0.2852 |
| May 10, 2024 | 0.293 |
| May 09, 2024 | 0.304 |
| May 08, 2024 | 0.3066 |
| May 07, 2024 | 0.3304 |
| May 06, 2024 | 0.4102 |
| May 03, 2024 | 3.17 |
| May 02, 2024 | 3.642 |
| May 01, 2024 | 4.130 |
| April 30, 2024 | 4.059 |
| April 29, 2024 | 3.721 |
| April 26, 2024 | 3.713 |
| April 25, 2024 | 4.067 |
| April 24, 2024 | 4.114 |
| April 23, 2024 | 4.098 |
| April 22, 2024 | 4.098 |
| April 19, 2024 | 4.082 |
| April 18, 2024 | 4.240 |
| April 17, 2024 | 4.252 |
| April 16, 2024 | 4.248 |
| April 15, 2024 | 4.145 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.153 |
| April 11, 2024 | 4.279 |
| April 10, 2024 | 4.130 |
| April 09, 2024 | 4.122 |
| April 08, 2024 | 4.012 |
| April 05, 2024 | 3.949 |
| April 04, 2024 | 4.153 |
| April 03, 2024 | 4.295 |
| April 02, 2024 | 4.413 |
| April 01, 2024 | 4.916 |
| March 31, 2024 | |
| March 28, 2024 | 4.156 |
| March 27, 2024 | 4.363 |
| March 26, 2024 | 4.096 |
| March 25, 2024 | 4.116 |
| March 22, 2024 | 4.169 |
| March 21, 2024 | 4.056 |
| March 20, 2024 | 4.056 |
| March 19, 2024 | 4.035 |
| March 18, 2024 | 3.855 |
| March 15, 2024 | 3.962 |
| March 14, 2024 | 3.828 |
| March 13, 2024 | 4.283 |
| March 12, 2024 | 4.136 |
| March 11, 2024 | 3.782 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2799
Minimum
May 15 2024
8.489
Maximum
Apr 14 2022
2.134
Average
1.796
Median
Price to Book Value Benchmarks
| Integra Lifesciences Holdings Corp | 0.7482 |
| Perspective Therapeutics Inc | 4.333 |
| Electromed Inc | 3.333 |
| Xtant Medical Holdings Inc | 1.967 |
| Asensus Surgical Inc | 5.437 |
Price to Book Value Related Metrics
| PS Ratio | 12.89 |
| Price | 0.3859 |
| Earnings Yield | -313.3% |
| Market Cap | 23.35M |